Patents by Inventor Udo Hoss

Udo Hoss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210267500
    Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.
    Type: Application
    Filed: May 3, 2021
    Publication date: September 2, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Kahn
  • Publication number: 20210251530
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes an array two or more discontiguous sensing elements deposited on a substrate surface, where the sensing elements comprise one or more droplets of a sensing element formulation.
    Type: Application
    Filed: April 14, 2021
    Publication date: August 19, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Publication number: 20210236028
    Abstract: An analyte sensor and methods and systems related thereto, where at least one or more of a lower portion of a sensor tail substrate, at least one electrode, a sensing element, a membrane, and an optional non-electrochemical functional layer comprise an antimicrobial quality. Asymmetric, double-sided adhesive binders suitable for adhering the analyte sensor to a skin surface comprising a non-woven scrim, a first pressure-sensitive adhesive layer, a second pressure-sensitive adhesive layer. Overbandages comprising a vapor-permeable backing, an aperture to circumferentially surround a sensor housing, a contact adhesive layer, first and second peelable release liners, and a third peelable release liner disposed upon an anchoring adhesive strip of the contact adhesive layer.
    Type: Application
    Filed: May 17, 2019
    Publication date: August 5, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jonathan D. MCCANLESS, Udo HOSS, Benjamin J. FELDMAN, Frank David FUJIMOTO, Steven T. Mitchell
  • Publication number: 20210219887
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Application
    Filed: April 2, 2021
    Publication date: July 22, 2021
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Publication number: 20210219886
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Application
    Filed: April 2, 2021
    Publication date: July 22, 2021
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Patent number: 11051725
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: July 6, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Patent number: 11051724
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: July 6, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20210190719
    Abstract: Methods and analyte sensors including a sensor tail comprising at least a first working electrode and a second working electrode that are spaced apart from one another along a length of the sensor tail. A first active area is disposed upon a surface of the first working electrode and a second active area is disposed upon a surface of the second working electrode, the first active area and the second active area being responsive to different analytes. A mass transport limiting membrane is deposited upon the first active area and the second active area by sequential dip coating operations, and the mass transport limiting membrane comprises a bilayer membrane portion overcoating the first active area and a homogeneous membrane portion overcoating the second active area.
    Type: Application
    Filed: January 18, 2021
    Publication date: June 24, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: John V. LaTour, Jonathan D. McCanless, Stephen Oja, Tianmei Ouyang, Kevin Paul Wallis, Benjamin J. Feldman, Udo Hoss, Suyue Qian
  • Publication number: 20210190718
    Abstract: Analyte sensors responsive at low working electrode potentials may comprise an active area upon a surface of a working electrode, wherein the active area comprises a polymer, a redox mediator covalently bonded to the polymer, and at least one analyte-responsive enzyme covalently bonded to the polymer. A specific redox mediator responsive at low potential may have a structure of wherein G is a linking group covalently bonding the redox mediator to the polymer. A mass transport limiting membrane permeable to the analyte may overcoat the active area. In some sensor configurations, the mass transport limiting membrane may comprise a membrane polymer crosslinked with a branched crosslinker comprising three or more crosslinkable groups, such as polyethylene glycol tetraglycidyl ether.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 24, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: John V. LaTour, Jonathan D. McCanless, Stephen Oja, Tianmei Ouyang, Kevin Paul Wallis, Benjamin J. Feldman, Udo Hoss, Suyue Qian
  • Patent number: 11006872
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: May 18, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Patent number: 11006871
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: May 18, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Patent number: 11006870
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: May 18, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Publication number: 20210128029
    Abstract: Methods, computers, and systems used to improve accuracy of analyte level measurement of an in vivo positioned analyte sensor are disclosed herein. The methods, computers, and systems disclosed herein may be used to provide a calibrated analyte level. Specific embodiments relate to methods, computers, and systems for improving accuracy of glucose measurement of an in vivo positioned glucose sensor.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Inventors: Udo Hoss, Erwin S. Budiman
  • Publication number: 20210128027
    Abstract: Analyte sensors and methods of use thereof, the analyte sensors comprising a base substrate, a first conductive layer positioned on a first side of the base substrate and a fiducial mark positioned on a portion of the analyte sensor. The fiducial mark is indicative of a location of at least the first conductive layer on the base substrate.
    Type: Application
    Filed: January 4, 2021
    Publication date: May 6, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mohammad E. Moein, Louis G. Pace, Udo Hoss, Phu X. Le, Samuel M. Curry
  • Patent number: 10993646
    Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: May 4, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Kahn
  • Publication number: 20210121106
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: November 9, 2020
    Publication date: April 29, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20210113124
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.
    Type: Application
    Filed: December 30, 2020
    Publication date: April 22, 2021
    Inventors: Phillip Yee, Christopher A. Thomas, Udo Hoss, Lei He, Michael R. Love
  • Publication number: 20210068722
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20210068721
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20210038134
    Abstract: A system and method for controlling and monitoring a diabetes-management system through the use of a model that predicts or estimates future dynamic states of glucose and insulin from variables such as insulin delivery or exogenous glucose appearance as well as inherent physiological parameters. The model predictive estimator can be used as an insulin bolus advisor to give an apriori estimate of postprandial glucose for a given insulin delivery profile administered with a known meal to optimize insulin delivery; as a supervisor to monitor the operation of the diabetes-management system; and as a model predictive controller to optimize the automated delivery of insulin into a user's body to achieve a desired blood glucose profile or concentration. Open loop, closed-loop, and semi-closed loop embodiments of the invention utilize a mathematical metabolic model that includes a Minimal Model, a Pump Delivery to Plasma Insulin Model, and a Meal Appearance Rate Model.
    Type: Application
    Filed: October 29, 2020
    Publication date: February 11, 2021
    Inventors: GARRY M. STEIL, SAMI S. KANDERIAN, JR., MARTIN T. CANTWELL, UDO HOSS